Today's News | Note: News feeds may no longer be available for the articles on this page.

ViroPharma Drops After Transplant Drug Fails in Study 12:12 PM 2/9/2009
Bloomberg - USA
ViroPharma Inc lost more than half its value after its experimental drug maribavir for patients receiving bone-marrow transplants failed. The drug did not reduce cytomegalovirus which can be deadly in people with HIV, cancer, or transplanted organs. ...

Danish Drug Maker to Buy US Firm Ovation 6:46 AM 2/9/2009
Wall Street Journal - USA
Lundbeck A/S agreed to acquire Ovation Pharmaceuticals Inc for up to $900 million. It strengthens its pipeline treating central nervous system disorders. ...

Glaxo Considers Buying Indian Drug Maker 4:33 PM 2/6/2009
Wall Street Journal - USA
GlaxoSmithKline has moved aggressively into emerging markets and now talks to buy Indian generic-drug company Piramal Healthcare Ltd for $1.5 billion. ...

Johnson & Johnson submits schizophrenia drug data 1:21 PM 2/6/2009
Forbes - NY,USA
Johnson & Johnson's submits data for schizophrenia drug candidate paliperidone palmitate responding to an FDA request issued in August. ...

FDA Approves First Drug From Genetically Altered Animals 12:50 PM 2/6/2009
Wall Street Journal - USA
Atryn developed by GTC Biotherapeutics Inc is made from the milk of genetically altered goats. Designed to treat a rare blood-clotting disorder known as hereditary antithrombin deficiency. ...

Glaxo pays up to $450 mln for Idenix AIDS drug 12:04 PM 2/6/2009
Reuters - USA
GlaxoSmithKline Plc will pay up to $450 million to access an experimental AIDS drug from Idenix Pharmaceuticals Inc. ...

Roche Eyes Biotech Licensing, Takeover Opportunities in China 5:28 AM 2/6/2009
Bloomberg - USA
Roche Holding AG could make its first acquisition of a Chinese biotech company. The company is also looking for rights to compounds developed in the country. ...

Fertility Drugs and Ovarian Cancer Not Linked, Study Says 3:38 AM 2/6/2009
New York Times - United States
The study did not rule out a cancer link altogether. It suggested that Clomid (clomiphene) may raise the risk of one form of ovarian cancer. ...

J&J seeks full FDA approval for HIV treatment 12:06 PM 2/5/2009
The Associated Press
J&J's Tibotec unit showed that 60 percent of patients taking Intelence for four months had undetectable levels of HIV in their blood (39 percent with placebo). ...

Procter & Gamble may exit pharmaceuticals business: report 7:12 AM 2/5/2009
MarketWatch - USA
Procter & Gamble Co may be looking to exit its $2 billion pharmaceutical business working with Goldman Sachs to find possible buyers. ...

Adding Erbitux to colon cancer drug mix not helpful 5:16 AM 2/5/2009
Reuters - USA
Adding ImClone's Erbitux to an already-potent drug combination offers no additional benefit against advanced colon cancer. Some patients fared worse. ...

US panel narrowly backs Dyax swelling disease drug 5:06 AM 2/5/2009
Reuters - USA
The advisory panel voted 6-5 to recommend that the US FDA allow sales of ecallantide for patients with hereditary angioedema (HAE). ...

GSK, Theravance asthma drug shows strong Phase II results 3:26 AM 2/5/2009
Bizjournals.com - Charlotte,NC,USA
GlaxoSmithKline and Theravance Inc said their mid-stage asthma drug performed well in three separate studies. ...

Novo Nordisk and Sciele launch diabetes drug 2:19 PM 2/4/2009
Forbes - NY,USA
Novo Nordisk and Sciele Pharma have launched type 2 diabetes drug PrandiMet combining Prandin (repaglinide) with the common generic drug metformin. ...

Teva's Copaxone gets EU approval in MS prevention 1:11 PM 2/4/2009
Forbes - NY,USA
European regulators approved Teva Pharmaceutical Industries' multiple sclerosis drug Copaxone as a preventative treatment. ...

<- Day Earlier | Today's News